Finance
Swiss Nylon maker EMS Chemie's sales dip, 2025 looks 'challenging'
Published by Global Banking and Finance Review
Posted on April 29, 2025
Global Banking and Finance Review
Company
Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Published by Global Banking and Finance Review
Posted on April 29, 2025
By Alberto Chiumento
(Reuters) -Swiss nylon maker EMS Chemie reported a 4% decline in first-quarter net sales on Tuesday, citing market-driven lower prices and cost levels and warning of "a particularly challenging economic environment" in 2025.
The European chemical industry, long suffering from weak demand and high production costs, faces uncertainty as European leaders seek to dissuade U.S. President Donald Trump from imposing planned tariffs on U.S. imports of European goods.
The announcement of additional tariffs has contributed to inventory build-ups and persistent inflation in the United States, EMS Chemie said.
The group reported net sales dropped to 522 million Swiss francs ($634 million) from 545 million Swiss francs the previous year, but the results were in line with company forecast, which in February 2025 projected annual net sales to remain below levels seen in 2024.
"Sales were impacted by a subdued first quarter and a weakening global economy," said Vontobel analyst Sibylle Bischofberger.
EMS added that in China economic stimulus packages announced by the government had not shown any effect yet.
EMS is a supplier of the world's largest EV maker, China's BYD . The company makes lightweight polymer car parts, which are especially useful in electric vehicles, which typically weigh more due to heavy batteries.
Bischofberger added that although ongoing sales initiatives showed some results, they were unable to offset the difficult environment.
EMS said in February - before the official U.S. tariff announcement in April - that it had taken steps to mitigate any impact from tariffs, and it "will remain unaffected".
Vontobel estimates that its tariff exposure is around 5% of total sales.
The company reaffirmed its outlook for earnings before interest and tax, projecting a slight increase over levels seen in 2024.
($1 = 0.8237 Swiss francs)
(Reporting by Alberto Chiumento in GdanskEditing by Sherry Jacob-Phillips and Peter Graff)